Systemic Lupus Erythematosus in Pregnancy: Evidence-Based Strategies for Improved Outcomes

Although systemic lupus erythematosus (SLE) in pregnancy is regarded as high risk, with advances in risk stratification, safer immunosuppressive options, and adherence to international guidelines, most women with well-controlled disease can achieve successful pregnancy outcomes. Preconception counseling, disease remission for at least six months before conception, and coordinated multidisciplinary care between rheumatologists, obstetricians, and maternal–fetal medicine specialists are central to minimizing complications. Diligent trimester-specific monitoring, continued use of hydroxychloroquine, appropriate anticoagulation when indicated, and timely differentiation of lupus nephritis from preeclampsia are crucial for maternal and fetal safety. Postpartum care, including close surveillance for flares, safe breastfeeding practices, and effective contraception, further enhances long-term outcomes. Individualized, evidence-based, and multidisciplinary care improves pregnancy outcomes in women with SLE, supporting safer motherhood and healthier offspring.